Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1999-3-22
|
pubmed:abstractText |
4-Hydroxy-2,5-dimethyl-3(2H)-furanone (HDMF) and 2(or 5)-ethyl-4-hydroxy-5(or 2)-methyl-3(2H)-furanone (EHMF) are known to inhibit cataract development in spontaneous cataract rats (ICR/f). Forty-five acylated hydroxyfuranone derivatives were designed and synthesized for an anti-cataract test, and their hydrophobic constants were also tested. Among these derivatives, 2,5-dimethyl-4-pivaloyloxy-3(2H)-furanone (HDMF pivalate) exerted a marked protective effect against the development of cataract in a galactose-induced model using cultured rat lens (in vitro). When tested on an ICR/f cataract model (in vivo), HDMF pivalate showed more significant inhibition of cataract development than parent compound HDMF. This derivative is more lipophilic than HDMF, so that HDMF pivalate can penetrate the cornea more easily than HDMF. The inhibition of cataract development by HDMF converted from HDMF pivalate is supported by the fact that HDMF was observed in the lens of ICR/f rats treated with HDMF pivalate.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0916-8451
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2145-54
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9972235-Acylation,
pubmed-meshheading:9972235-Animals,
pubmed-meshheading:9972235-Cataract,
pubmed-meshheading:9972235-Disease Susceptibility,
pubmed-meshheading:9972235-Furans,
pubmed-meshheading:9972235-Galactose,
pubmed-meshheading:9972235-Hydrolysis,
pubmed-meshheading:9972235-Linear Models,
pubmed-meshheading:9972235-Molecular Weight,
pubmed-meshheading:9972235-Rats,
pubmed-meshheading:9972235-Rats, Inbred Strains
|
pubmed:year |
1998
|
pubmed:articleTitle |
Synthesis of 4-hydroxy-3(2H)-furanone acyl derivatives and their anti-cataract effect on spontaneous cataract rats (ICR/f).
|
pubmed:affiliation |
Research and Development Division, Kikkoman Corporation, Chiba, Japan.
|
pubmed:publicationType |
Journal Article
|